<DOC>
	<DOCNO>NCT01205789</DOCNO>
	<brief_summary>The purpose Universal Registry assess proportion reason subject angiographically significant ULMCA disease require revascularization time course study randomize ; compare baseline characteristic subject ; assess variability randomization eligibility treatment pattern .</brief_summary>
	<brief_title>EXCEL Clinical Trial ( Universal Registry )</brief_title>
	<detailed_description>Approximately 100 consecutive subject otherwise meet enrollment criterion , analyze separately intermediate lesion subject , follow time initial treatment per standard care intend PCI , CABG medical treatment .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Coronary Occlusion</mesh_term>
	<criteria>Subjects either eligible randomization reason randomize consent Universal Registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Drug elute stent</keyword>
	<keyword>Stents</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Left Main Coronary Artery Disease</keyword>
</DOC>